BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35748390)

  • 1. Meta-analysis: efficacy of exclusive enteral nutrition as induction therapy on disease activity index, inflammation and growth factors in paediatric Crohn's disease.
    Sohouli MH; Fatahi S; Farahmand F; Alimadadi H; Seraj SS; Rohani P
    Aliment Pharmacol Ther; 2022 Aug; 56(3):384-395. PubMed ID: 35748390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis.
    Yu Y; Chen KC; Chen J
    World J Pediatr; 2019 Feb; 15(1):26-36. PubMed ID: 30666565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
    Zhou S; Huang Z; Hou W; Lin Y; Yu J
    Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease.
    Swaminath A; Feathers A; Ananthakrishnan AN; Falzon L; Li Ferry S
    Aliment Pharmacol Ther; 2017 Oct; 46(7):645-656. PubMed ID: 28815649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteral nutritional therapy for induction of remission in Crohn's disease.
    Zachos M; Tondeur M; Griffiths AM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000542. PubMed ID: 17253452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exclusive Enteral Nutrition Therapy in Paediatric Crohn's Disease Results in Long-term Avoidance of Corticosteroids: Results of a Propensity-score Matched Cohort Analysis.
    Connors J; Basseri S; Grant A; Giffin N; Mahdi G; Noble A; Rashid M; Otley A; Van Limbergen J
    J Crohns Colitis; 2017 Sep; 11(9):1063-1070. PubMed ID: 28575325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteral nutritional therapy for inducing remission of Crohn's disease.
    Zachos M; Tondeur M; Griffiths AM
    Cochrane Database Syst Rev; 2001; (3):CD000542. PubMed ID: 11686966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn's disease.
    Grover Z; Burgess C; Muir R; Reilly C; Lewindon PJ
    J Crohns Colitis; 2016 Oct; 10(10):1159-64. PubMed ID: 26980840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of induction therapy with exclusive enteral nutrition in pediatric Crohn's disease].
    Luo YY; Fang YH; Yu JD; Xu LJ; Sun MF; Cheng Q; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jun; 24(6):626-630. PubMed ID: 35762427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of exclusive enteral therapy in adult Crohn's disease.
    Mitrev N; Huang H; Hannah B; Kariyawasam VC
    BMJ Open Gastroenterol; 2021 Sep; 8(1):. PubMed ID: 34580154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated exclusive enteral nutrition in the treatment of paediatric Crohn's disease: predictors of efficacy and outcome.
    Frivolt K; Schwerd T; Werkstetter KJ; Schwarzer A; Schatz SB; Bufler P; Koletzko S
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1398-407. PubMed ID: 24779671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Response to Exclusive Enteral Nutrition in Newly Diagnosed Crohn´s Disease in Children: PRESENCE Study from SEGHNP.
    Moriczi M; Pujol-Muncunill G; Martín-Masot R; Jiménez Treviño S; Segarra Cantón O; Ochoa Sangrador C; Peña Quintana L; González Santana D; Rodríguez Martínez A; Rosell Camps A; Armas H; Barrio J; González de Caldas R; Rodríguez Salas M; Balmaseda Serrano E; Donat Aliaga E; Bodas Pinedo A; Vaquero Sosa E; Vecino López R; Solar Boga A; Moreno Álvarez A; Sánchez Sánchez C; Tolín Hernani M; Gutiérrez Junquera C; Martinón Torres N; Leis Trabazo MR; Eizaguirre FJ; García Peris M; Medina Benítez E; Fernández Caamaño B; Vegas Álvarez AM; Crespo Valderrábano L; Alonso Vicente C; Rubio Santiago J; Galera-Martínez R; García-Romero R; Ros Arnal I; Fernández Cebrián S; Lorenzo Garrido H; Viada Bris JF; Velasco Rodríguez-Belvis M; Bartolomé Porro JM; Blanco Rodríguez M; Barros García P; Botija G; Chicano Marín FJ; La Orden Izquierdo E; Crehuá-Gaudiza E; Navas-López VM; Martín-de-Carpi J
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32272604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive enteral nutrition effect on the clinical course of pediatric Crohn's disease: a single center experience.
    Scarpato E; Strisciuglio C; Martinelli M; Russo M; Cenni S; Casertano M; Serra MR; Staiano A; Miele E
    Eur J Pediatr; 2020 Dec; 179(12):1925-1934. PubMed ID: 32734315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Active Crohn's Disease in Children Using Partial Enteral Nutrition Combined with a Modified Crohn's Disease Exclusion Diet: A Pilot Prospective Cohort Trial on Clinical and Endoscopic Outcomes.
    Urlep D; Orel R; Kunstek P; Benedik E
    Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Exclusive enteral nutrition continues to be first line therapy for pediatric Crohn's disease in the era of biologics].
    Navas-López VM; Blasco-Alonso J; Lacasa Maseri S; Girón Fernández-Crehuet F; Serrano Nieto MJ; Vicioso Recio MI; Sierra Salinas C
    An Pediatr (Barc); 2015 Jul; 83(1):47-54. PubMed ID: 24704330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn's disease.
    Jongsma MME; Vuijk SA; Cozijnsen MA; van Pieterson M; Norbruis OF; Groeneweg M; Wolters VM; van Wering HM; Hojsak I; Kolho KL; van Wijk MP; Teklenburg-Roord STA; de Meij TGJ; Escher JC; de Ridder L
    Eur J Pediatr; 2022 Aug; 181(8):3055-3065. PubMed ID: 35672586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease.
    Grover Z; Muir R; Lewindon P
    J Gastroenterol; 2014 Apr; 49(4):638-45. PubMed ID: 23636735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.
    Day AS; Whitten KE; Lemberg DA; Clarkson C; Vitug-Sales M; Jackson R; Bohane TD
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1609-14. PubMed ID: 16928225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical progress in the two years following a course of exclusive enteral nutrition in 109 paediatric patients with Crohn's disease.
    Cameron FL; Gerasimidis K; Papangelou A; Missiou D; Garrick V; Cardigan T; Buchanan E; Barclay AR; McGrogan P; Russell RK
    Aliment Pharmacol Ther; 2013 Mar; 37(6):622-9. PubMed ID: 23360085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.